This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Jounce Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 1,476,686 | 2.81% |
| General Public | 4,038,297 | 7.67% |
| VC/PE Firms | 4,259,653 | 8.09% |
| Public Companies | 5,539,727 | 10.5% |
| Hedge Funds | 11,270,928 | 21.4% |
| Institutions | 26,050,177 | 49.5% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 5,539,727 | US$10.4m | 0% | no data | |||
| 5,300,087 | US$10.0m | 0% | 1.53% | |||
| 4,259,653 | US$8.0m | 0% | 0.33% | |||
| 3,270,531 | US$6.1m | -0.19% | no data | |||
| 3,160,841 | US$5.9m | 0% | 0.15% | |||
| 2,810,000 | US$5.3m | 0% | 1.57% | |||
| 2,553,500 | US$4.8m | -0.7% | no data | |||
| 2,107,221 | US$4.0m | 29% | no data | |||
| 1,828,681 | US$3.4m | 0% | no data | |||
| 1,663,489 | US$3.1m | -54.4% | 0.26% | |||
| 1,640,949 | US$3.1m | -0.34% | no data | |||
| 1,400,000 | US$2.6m | 0% | 0.37% | |||
| 1,087,961 | US$2.0m | 0% | 1.6% | |||
| 1,024,423 | US$1.9m | 0% | 0.01% | |||
| 808,684 | US$1.5m | 24.7% | no data | |||
| 767,117 | US$1.4m | 14.4% | no data | |||
| 715,037 | US$1.3m | -29% | no data | |||
| 581,300 | US$1.1m | 110% | no data | |||
| 500,123 | US$940.2k | 0% | 0.23% | |||
| 482,450 | US$907.0k | 279% | 0.2% | |||
| 444,720 | US$836.1k | -12.4% | no data | |||
| 424,490 | US$798.1k | 3,310% | no data | |||
| 380,500 | US$715.4k | 34.1% | no data | |||
| 356,638 | US$670.5k | 7.05% | no data | |||
| 335,533 | US$630.8k | 18.2% | no data |